您的购物车当前为空
别名 TP3076
CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM).

CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 20,500 | 3-6月 | |
| 50 mg | ¥ 27,300 | 3-6月 | |
| 100 mg | ¥ 35,500 | 3-6月 |
CH-0793076 相关产品
| 产品描述 | CH-0793076, a hexacyclic camptothecin analog, is an active drug and major metabolite of TP300. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein). CH-0793076 inhibits DNA topoisomerase I (IC50: 2.3 μM). |
| 靶点活性 | Topo I:2.3 μM |
| 体外活性 | CH0793076 (6 days at 37°C) displays antiproliferative activity against PC-6/BCRP and PC-6/pRC cells (IC50: 0.35 and 0.18 nM). |
| 体内活性 | TP300 (1-100 mg/kg; bolus intravenous injection once per week for 3 weeks, for a total of three doses) demonstrates over 50% tumor growth inhibition across all nine models. |
| 别名 | TP3076 |
| 分子量 | 458.51 |
| 分子式 | C26H26N4O4 |
| CAS No. | 534605-78-2 |
| 密度 | 1.46 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容